| [姓名table_Authors] | 电话 | 邮箱 | 登记编号 | [Table_Invest] 评级： | 增持 | | --- | --- | --- | --- | --- | --- | | 秦和平(分析师) | 0755-23976666 | qinheping@gtht.com | S0880523110003 | | | | 高翩然(分析师) | 0755-80305701 | gaopianran@gtht.com | S0880525040066 | [当前价格 Table_CurPrice] (港元)： | 81.25 | 全球 AIGC 视频商业化加速，可灵打通"技术-生态-变现"闭 环释放长期价值 快手-W(1024) 快手可灵专题报告 本报告导读： 可灵通过 2.5 Turbo（基础能力升级）-O1（全模态与成片能力突破）-2.6（音画一体 化革命）的阶梯式迭代，完成从 "高质量视频生成" 到 "重构 AI 视频创作工作流" 的技术升级。 投资要点： | 财务摘要(百万人民币) | 2023A | 2024A | 2025E | 2026E | 2027E | | --- ...

Investment Rating - The investment rating for the company is "Buy" with a current price of 30.44 HKD and a target value of 50.25 HKD [4]. Core Insights - The report anticipates a stabilization in gaming revenue, steady performance in office software, and a rebound in profits for Q4. The company is expected to see a 10% quarter-on-quarter revenue increase in Q4 2025, despite a year-on-year decline of 5% [8][10]. - The gaming segment is projected to experience a year-on-year revenue decline of 32% and a quarter-on-quarter decline of 2% in Q4 2025, with new game "Goose Duck" exceeding expectations [8][10]. - The office software segment is expected to grow by 19% year-on-year in Q4 2025, driven by government projects and the enhancement of WPS 365 as a global AI collaboration platform [8][10]. - The cloud segment is forecasted to grow by 20% year-on-year in Q4 2025, with continued high capital expenditures expected in 2026 [8][10]. Financial Forecasts - Revenue projections for the company are as follows (in million RMB): - 2023A: 8,534 - 2024A: 10,318 - 2025E: 9,730 - 2026E: 11,571 - 2027E: 13,416 - The growth rates are expected to be 11.7% for 2023, 20.9% for 2024, -5.7% for 2025, 18.9% for 2026, and 15.9% for 2027 [3][10]. - The EBITDA is projected to be 1,268 million RMB in 2023, increasing to 3,511 million RMB by 2027 [3][10]. - The net profit attributable to shareholders is expected to rise from 483 million RMB in 2023 to 2,081 million RMB in 2027, with significant growth in 2024 [3][10]. Business Segment Analysis - Gaming revenue is expected to be 3,977 million RMB in 2023, with a decline to 3,768 million RMB in 2025, followed by a recovery to 4,239 million RMB in 2026 [9][10]. - Office revenue is projected to grow from 4,557 million RMB in 2023 to 5,962 million RMB in 2025, and further to 7,332 million RMB in 2026 [9][10]. - The cloud segment is anticipated to generate significant growth, with revenue expected to reach 12,215 million RMB by 2026 [9][10]. Valuation and Investment Recommendation - The report suggests a valuation of 50.25 HKD per share based on a combination of gaming, office, and cloud business valuations, applying a PE ratio of 13x for gaming, 35x for office, and 3x PS for cloud [12][16]. - The overall recommendation remains "Buy" based on the expected performance and growth potential of the company [12].

[Table_Page] 公告点评|耐用消费品与服装 证券研究报告 | [Table_Title] 【 广 发 纺 服 | 海 外 】 特 步 国 际 & | | --- | --- | | （01368.HK） | | | 25Q4 | 主品牌稳健，索康尼环比提速 | [Table_Summary] 核心观点： 盈利预测：*本文如无特殊说明，货币单位均为人民币，1HKD=0.90CNY | [Table_ 单位 Finance] :人民币百万元 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 主营收入 | 12,743 | 13,577 | 14,416 | 15,516 | 16,868 | | 增长率（ % ） | -1.5% | 6.5% | 6.2% | 7.6% | 8.7% | | EBITDA | 2,120 | 2,379 | 2,343 | 2,571 | 2,813 | | 归母净利润 | 1,030 | 1,238 | 1,362 | 1,514 | 1,668 | | ...

Investment Rating - The report initiates coverage with a "Buy" rating for Baidu Group, indicating a positive outlook for the company's stock performance over the next 12 months [6]. Core Insights - Baidu has launched its new generative AI model, Wenxin 5.0, which boasts 2.4 trillion parameters and has outperformed competitors in over 40 benchmark evaluations [2]. - The company is undergoing a significant transformation towards AI, with its advertising business facing short-term pressures, while its intelligent cloud and autonomous driving sectors show high growth potential [4]. - Baidu's monthly active users for its app have reached 708 million, and approximately 70% of mobile search results now include AI-generated content, enhancing its competitive edge in AI [3]. Financial Projections - Revenue forecasts for Baidu Group from 2025 to 2027 are projected at 133.3 billion, 142.3 billion, and 153.8 billion RMB, reflecting growth rates of 0.13%, 6.76%, and 8.12% respectively [4][5]. - Adjusted net profits for the same period are expected to be 186 billion, 202 billion, and 230 billion RMB, with adjusted EPS projected at 6.78, 7.33, and 8.36 RMB [4][5]. - The current stock price corresponds to adjusted P/E ratios of 22, 20, and 18 for the years 2025, 2026, and 2027 respectively [4]. Business Developments - Baidu's autonomous driving service, "LuoBo Kuaipao," has achieved 3.1 million orders in Q3 2025, marking a year-on-year growth of 212% [3]. - The company has expanded its global footprint, entering markets in Switzerland, Abu Dhabi, and Hong Kong [3]. - Baidu's Kunlun chip, a leading AI chip in China, is set to have a shipment volume of 69,000 units in 2024, enhancing its capabilities in AI cluster construction [2].

[Table_Page] 公司深度研究|房地产Ⅱ 证券研究报告 | 地 | [Table_Title] 【 广 发 | 产 & | 海 | 外 | 】 | 贝 | 壳 | | --- | --- | --- | --- | --- | --- | --- | --- | | -W(02423.HK)/贝壳(BEKE) | | | | | | | | | 系列二 | —洞见贝壳 | | | | | | | 如何看待 26 年市场环境下贝壳的业绩弹性 [Table_Summary] 核心观点： 盈利预测（货币单位如无特别说明均为人民币）： | [Table_Finance] | | 2023 | 2024 | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | --- | | 营业收入（百万元） | | 77,777 | 93,457 | 94,308 | 95,240 | 104,660 | | 增长率 （ ） | % | 28% | 20% | 1% | 1% | 10% | | EBITDA（百万元） | | 8,023 | 6,622 ...

(01368) 型公司 纺织服饰 2026 年 01 月 25 日 主品牌表现稳健,索康尼延续强劲趋势 报告原因:有业绩公布需要点评 婴人(维持) | 市场数据: | 2026 年 01 月 23 日 | | --- | --- | | 收盘价（港币） | 5.08 | | 恒生中国企业指数 | 9160.81 | | 52 周最高/最低（港币） | 6.83/4.46 | | H 股市值（亿港币） | 142.55 | | 流通 H 股 (百万股) | 2,806.07 | | 汇率（港币/人民币） | 0.8968 | 一年内股价与基准指数对比走势: 76% 26% 资料来源：Bloomberg 证券分析师 王立平 A0230511040052 wanglp@swsresearch.com 刘佩 A0230523070002 liupei@swsresearch.com 联系人 刘佩 A0230523070002 liupei@swsresearch.com 申万宏源研究微信服务号 投资要点: 财务数据及盈利预测 | 货币单位:人民币 | FY2023 | FY2024 | FY2025E | FY202 ...

Investment Rating - The report assigns a "Buy" rating to the company [4][15]. Core Insights - The biopharmaceutical industry is rapidly growing, leading to increased demand for consumables such as filters. The global biopharmaceutical upstream market is expected to grow at a compound annual growth rate (CAGR) of 10.4% from 2024 to 2030, reaching a market size of $44.7 billion by 2035 [1][4]. - The company is a leading medical device provider in China, offering comprehensive solutions across various specialized fields. As of June 30, 2025, the company holds 927 product registrations and 1,084 patents domestically, with 905 product registrations and 156 patents overseas [1][4]. - The company is expected to achieve net profits of 2.09 billion, 2.29 billion, and 2.51 billion yuan for the years 2025, 2026, and 2027, respectively, with year-on-year growth rates of 1.18%, 9.37%, and 9.62% [2][15]. Summary by Sections Company Overview - The company, established in 1988, has become a leader in the medical device and consumables sector in China, focusing on clinical care, orthopedic consumables, drug packaging, and blood technology [20][21]. - The company has a stable shareholding structure, with 46.51% owned by Weigao Group, ensuring experienced management [21][23]. Industry Outlook - The global medical device market is projected to grow from $456.6 billion in 2020 to $623 billion in 2024, with a CAGR of 8.1%. By 2035, the market size is expected to reach $1,157.6 billion [43][44]. - The Chinese medical device market is also expanding, with a projected growth from 729.8 billion yuan in 2020 to 941.7 billion yuan in 2024, at a CAGR of 6.6% [46][48]. Product Lines and Growth Drivers - The company is diversifying its product lines, focusing on high-end consumables and expanding into new markets. The automatic injection pen market is expected to grow significantly, driven by domestic and international demand [11][13]. - The company anticipates revenue growth in various segments, including medical devices, drug packaging, interventional products, orthopedic products, and blood management, with specific growth rates projected for 2025-2027 [11][12][31]. Financial Projections - The company forecasts revenues of 13.42 billion, 14.74 billion, and 16.22 billion yuan for 2025, 2026, and 2027, respectively, with corresponding growth rates of 2.52%, 9.83%, and 10.04% [2][15]. - The earnings per share (EPS) are projected to increase from 0.46 in 2025 to 0.55 in 2027, reflecting the company's growth strategy and market positioning [2][15].

上 市 公 司 纺织服饰 2026 年 01 月 25 日 特步国际 (01368) —— 主品牌表现稳健，索康尼延续强劲趋势 报告原因：有业绩公布需要点评 一年内股价与基准指数对比走势： -24% 26% 76% HSCEI 特步国际 资料来源：Bloomberg 证券分析师 王立平 A0230511040052 wanglp@swsresearch.com 刘佩 A0230523070002 liupei@swsresearch.com 联系人 刘佩 A0230523070002 liupei@swsresearch.com 买入（维持） | 市场数据： | 2026 年 01 月 23 日 | | --- | --- | | 收盘价（港币） | 5.08 | | 恒生中国企业指数 | 9160.81 | | 52 周最高/最低（港币） | 6.83/4.46 | | H 股市值（亿港币） | 142.55 | | 流通 H 股（百万股） | 2,806.07 | | 汇率（港币/人民币） | 0.8968 | 投资要点： 财务数据及盈利预测 | 货币单位：人民币 | FY2023 | FY2024 | ...

[Table_Page] 跟踪研究|软件与服务 证券研究报告 [Table_Title] 【广发计算机&海外】金山云（03896.HK） 前瞻：预计25Q4 AI云高增长，26年延续高资本开支 [Table_Summary] 核心观点： 盈利预测：备注：报告中汇率为 1 港元=0.893 人民币；货币若无特别说明均为人民币。 | [Table_ 单位:Finance] 人民币百万元 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入（百万元） | 7,047 | 7,785 | 9,481 | 12,215 | 14,687 | | 增长率 （ % ） | -13.8% | 10.5% | 21.8% | 28.8% | 20.2% | | 经调整EBITDA（百万元） | -265 | 639 | 2,292 | 4,072 | 5,657 | | 经调整净利润（百万元） | -1,291 | -825 | -567 | -519 | -387 | | EPS（元/股） | -0.61 ...

Investment Rating - The report gives a "Buy" rating for 康耐特光学 (2276.HK) with a target price of 61.10 HKD [2][10]. Core Insights - 康耐特光学 is a leading global manufacturer of resin lenses, ranking second in sales volume globally. The company has shown a compound annual growth rate (CAGR) of 15.8% in revenue and 32.7% in net profit from 2018 to 2024, driven by both volume and price increases [7][8]. - The traditional lens market is expected to grow, with a projected CAGR of 5.8% in production and 6.2% in retail sales from 2024 to 2029. The demand for smart glasses is also anticipated to surge, with global shipments expected to reach approximately 61.07 million units by 2029 [7][8]. - The company has a strong competitive edge due to its pricing advantages, access to high-refractive index lens materials, and exceptional customization capabilities. The partnership with 歌尔股份 is expected to enhance its smart glasses business [7][8]. Summary by Sections Company Overview - 康耐特光学 was established in 1996 and has become a leading resin lens manufacturer, covering a full range of products including standardized, functional, and customized lenses. The company has a production capacity of over 7 million SKUs [7][13][16]. Traditional Lens Market - The traditional lens market is driven by health needs and technological advancements, with a significant increase in demand for high-refractive index lenses. The company is well-positioned to benefit from these trends [8][58]. Smart Glasses Market - The smart glasses segment is expected to open new growth opportunities, with 康耐特光学 actively engaging in R&D and partnerships to supply lenses for upcoming smart glasses products [8][9]. Financial Projections - Revenue and net profit forecasts for 2025-2027 are projected at 5.6 billion, 6.9 billion, and 8.4 billion RMB respectively, with corresponding P/E ratios of 47, 38, and 32 [2][10][31].